Plaque Psoriasis
Supporting Research and Treatment for Long-Term Chronic Skin Diseases
Maintaining a Patient-Centric Focus for Plaque Psoriasis Trials
Plaque psoriasis is the most common form of psoriasis – a chronic, immunologically mediated skin disease. Unlike more acute dermatologic diseases, plaque psoriasis can present more severe symptoms and health risks from comorbidities. Coupled with the mental and emotional strain of the disease, clinical trials can often face challenges ranging from recruitment to patient participation and retention.
Clinical studies of this nature require a more patient-centric approach to avoid costly delays and achieve results – a strategy aligning the trial with patient preferences.
Biorasi Brings Smart Solutions to Your Plaque Psoriasis Trials
With our 15 years of experience in common dermatology disorders and rare diseases, innovative project management, and digital technology, Biorasi can execute patient-centric solutions for existing and future plaque psoriasis studies:
- Our patient-centered strategy manages early interaction with the patient, helping sponsors understand the patient’s mindset, their health status, and what they expect from participating in the trial.
- Biorasi integrates our decentralized strategy into patient-centric solutions, leveraging telemedicine, home care, mobile vans, and ECOA/ePRO technology to reduce the travel burden and increase enrollment for immunocompromised patients.
- Our TALOS™ Control Center improves data intelligence for patient-centric trials – giving sponsors access to real-time reporting, facilitating data capture across physical sites and remote visits, and standardizing data to optimize results.
Connect with us to find the right strategy for your next dermatology trial. CONTACT US TODAY
